FDA inspection

Rigel Pharmaceuticals Inc: FDA inspection ending Dec 8, 2017

FDA inspection 1035429 · No Action Indicated (NAI) · South San Francisco, CA

Key facts

Inspection ID 1035429
Firm Rigel Pharmaceuticals Inc
FEI number 3004865166
Address 1180 Veterans Blvd
City South San Francisco
State CA
ZIP 94080-1985
Fiscal year 2018
Inspection end date Dec 8, 2017
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections